It is
very likely that over a hundred thousand seniors have suffered
reductions in their use of essential drugs and a higher
rate of serious adverse events and emergency room visits
associated with those reductions as a consequence of the
implementation of so called Fair PharmaCare. The Campbell
government cannot hide the research for another three years.
BC's
"Fair
PharmaCare Plan" started May 1, 2003. The government's
website boasted that: "Under the new plan, up to
280,000 BC families will pay less than they did in the past."
It didn't reveal how many families pay more than they did
in the past but you can get an idea by subtracting that
figure from the number who have received PharmaCare benefits
in past years (814,424
in 2002). On October 22, 2003, Colin
Hansen told the Legislature that: "We have already
put in place a contract with officials at the University
of British Columbia to make sure that this transition is
properly monitored using PharmaNet data, to make sure that
no senior and no British Columbian is negatively impacted
in terms of their ability - based on their ability to pay
- to get the medications that they need." The Auditor
General recently released a highly critical audit of the
PharmaCare program in which he quoted the Ministry's 2003/04
Annual Report as saying: "
any potential negative
impacts of Fair PharmaCare are being monitored, and that
preliminary evaluations indicate that drug use has not decreased
in either the senior or non-senior groups since implementation."
The Auditor General has confirmed (click
for his letter) that he and his staff did not see the
"preliminary evaluations" as they were not auditing
the Annual Report, but merely quoting from it.
There
are serious reasons to believe that the claim made in the
Ministry's Annual Report, as quoted in the Auditor's report,
is misleading. According to the Budget Transparency and
Accountability Act, the Ministry's 2003/04 Annual Report
had to be made available by August 31, 2004. That is just
3 months after the first full year of experience with the
new plan. It is inconceivable that research studies could
have been completed so quickly. The claim made by the Ministry
refers to total utilization by groups of people, seniors
and non-seniors. Of course some people, possibly those with
improved coverage, obtained more drugs while others obtained
fewer drugs. Aggregate utilization says nothing with
respect to the claim Hansen made that the program was being
monitored to make sure that no senior and no British Columbian
is negatively impacted. The promise referred to individuals,
not to aggregate group use of pharmaceuticals.
The
Ministry of Health had a standing agreement with the Centre
for Health Services and Policy Research (CHSPR) at UBC which
it subsequently amended to monitor the transition to Fair
Pharmacare. I have submitted a freedom
of information request for the report that should have
been the product of the contract Hansen referenced in 2002,
although the Ministry has yet to acknowledge receipt of
my March 22nd request. Despite time limits specified in
the Act, it can take a year or more to beat information
out of the Campbell government. It is particularly important
to obtain the research reports on the effect of the change
in PharmaCare because a
study of a similar change in Quebec found: "increased
cost-sharing for prescription drugs in elderly persons and
welfare recipients was followed by reductions in use of
essential drugs and a higher rate of serious adverse events
and ED visits associated with these reductions." That
study, published in the Journal of the American Medical
Association, wasn't based on glancing at aggregate drug
use; it studied individual drug use by a random sample of
93,950 elderly persons and 55,333 adult welfare medication
recipients 32 months before and 17 months after Quebec's
1996 introduction of a prescription coinsurance and deductible
cost-sharing policy.
In 2002,
British Columbians age 65 or over were eligible for one
of two PharmaCare plans: regular Plan A where seniors paid
a maximum of $25 towards the drug cost and dispensing fee
per prescription, to a yearly maximum of $275, or Plan A1
for seniors in receipt of premium assistance where they
paid a maximum of $10 towards the drug cost and dispensing
fee per prescription, to a yearly maximum of $200. In 2002,
413,274 seniors received $339,815,837 in benefits from PharmaCare.
Under
"Fair" PharmaCare the maximum amount paid and
the initial deductible before any benefits are paid depends
on income. Seniors with net annual family income of $40,000
don't receive any coverage until they've paid a deductible
of $400, after which they receive 75% coverage until they've
paid a total of $800. Deductibles and maximum self-payments
increase as income increases. The challenge for the researchers
is to follow the prescription drug use of a large random
sample of families, whose benefits were reduced, before
and after the 2003 policy change. The data exists for that
study. Since it is now almost three years after the implementation
of the policy change, it is likely that the study on the
Quebec change could have been replicated in BC. According
to the Ministry of Health's Annual Report, the Campbell
government intends to keep the study secret until after
the 2009 election. It is certain to face a challenge before
the Freedom of Information and Protection of Privacy Commissioner
if it follows that plan.